Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Intuitive Surgical shows no slowing

This article was originally published in The Gray Sheet

Executive Summary

Growth of robotic surgery systems firm continues to soar with second quarter sales of $87 mil., up 65% from the prior-year period, driven by strong performance from Intuitive Surgical's gynecologic sector, which became its second largest surgical segment. Hysterectomy was the fastest growing procedure, VP-Business Development & Strategic Planning Aleks Cukic noted during firm's Q2 earnings call July 26. The largest gainer two years running on "The Gray Sheet" OTC index, Intuitive shipped 39 of its million-dollar-plus da Vinci systems during the quarter, bringing the number of worldwide installations to 467 (1"The Gray Sheet" Jan. 23, 2006, p. 13)...

You may also be interested in...



NuVasive Boosts Artificial Disc Development, Stock; OTC Index Rises 15%

NuVasive will use profits gained from a series of 510(k)-cleared spinal devices to fuel artificial disc and nucleus replacement development in 2006

Oxford/AstraZeneca Vaccine Shows 70% Efficacy As Company Prepares Approval Filings

Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.

EBITDA Margin Of 33% Not Sustainable, Krka Underlines

Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.

UsernamePublicRestriction

Register

LL1134786

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel